OTCMKTS:NBHGF - Nobel Biocare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$18.25 0.00 (0.00 %)
(As of 11/18/2018 04:00 PM ET)
Previous Close$18.25
Today's Range$18.25 - $18.25
52-Week Range$16.35 - $19.50
VolumeN/A
Average VolumeN/A
Market Capitalization$2.26 billion
P/E RatioN/A
Dividend YieldN/A
Beta-0.24

Receive NBHGF News and Ratings via Email

Sign-up to receive the latest news and ratings for NBHGF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NBHGF
Previous Symbol
CUSIPN/A
Phone41-43-211-4200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares123,780,000
Market Cap$2.26 billion
OptionableNot Optionable

Nobel Biocare (OTCMKTS:NBHGF) Frequently Asked Questions

What is Nobel Biocare's stock symbol?

Nobel Biocare trades on the OTCMKTS under the ticker symbol "NBHGF."

How were Nobel Biocare's earnings last quarter?

Nobel Biocare Ag (OTCMKTS:NBHGF) issued its earnings results on Thursday, August, 21st. The company reported $0.17 EPS for the quarter, topping the Zacks' consensus estimate of $0.12 by $0.05. The company earned $191.67 million during the quarter, compared to the consensus estimate of $171.79 million. View Nobel Biocare's Earnings History.

Has Nobel Biocare been receiving favorable news coverage?

Headlines about NBHGF stock have trended very positive recently, InfoTrie reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nobel Biocare earned a media sentiment score of 4.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.

Who are some of Nobel Biocare's key competitors?

Some companies that are related to Nobel Biocare include DENTSPLY SIRONA (XRAY), Sartorius (SARTF), Biomerica (BMRA), BIOLASE (BIOL) and Remedent (REMI).

How do I buy shares of Nobel Biocare?

Shares of NBHGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nobel Biocare's stock price today?

One share of NBHGF stock can currently be purchased for approximately $18.25.

How big of a company is Nobel Biocare?

Nobel Biocare has a market capitalization of $2.26 billion.

What is Nobel Biocare's official website?

The official website for Nobel Biocare is http://www.nobelbiocare.com.

How can I contact Nobel Biocare?

Nobel Biocare's mailing address is P.O. Box 8058, Zurich Fl, V8. The company can be reached via phone at 41-43-211-4200 or via email at [email protected]


MarketBeat Community Rating for Nobel Biocare (OTCMKTS NBHGF)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  79
MarketBeat's community ratings are surveys of what our community members think about Nobel Biocare and other stocks. Vote "Outperform" if you believe NBHGF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NBHGF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel